Pathstone Family Office, LLC Athersys, Inc Transaction History

Pathstone Family Office, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Oct 23, 2023	BUY	$0.18 - $0.86 $72,300 - $345,435	401,669 New	401,669 $104,000
Q2 2022 Aug 15, 2022	BUY	$0.18 - $0.86 $57,621 - $275,304	320,122 Added 392.56%	401,669 $105,000
Q1 2022 May 16, 2022	BUY	$0.6 - $1.06 $1,618 - $2,858	2,697 Added 3.42%	81,547 $50,000
Q4 2021 Feb 14, 2022	BUY	$0.85 - $1.4 $1,275 - $2,100	1,500 Added 1.94%	78,850 $72,000
Q3 2021 Nov 16, 2021	BUY	$1.33 - $1.77 $42,965 - $57,179	32,305 Added 71.72%	77,350 $103,000
Q2 2021 Aug 31, 2021	BUY	$1.41 - $1.94 $63,513 - $87,387	45,045 New	45,045 $65,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.